On September 9, TLC Healthcare (TLC) introduced a rapid antigen testing program at their 11 residential aged care homes across Melbourne and Geelong. The rapid antigen test that TLC utilises is 95% effective and has been approved by the TGA in Australia and the FDA in the United States.
From September 9, TLC Healthcare (TLC) will be introducing a rapid antigen testing program at their 11 residential aged care homes located across Melbourne and Geelong. This program is a critical step in preparing for the changes that will be introduced when 80% of the Australian population is vaccinated against COVID-19.
TLC Healthcare (TLC) has been awarded 205 subsidised residential aged care places in the 2020 Aged Care Approvals Round (ACAR), which is 100% of their requested places. This is the highest number of aged care places allocated to a single provider in Australia.